Chantar, principal investigator at CIC bioGUNE and CIBERehd, has identified a new therapeutic target for cholangiocarcinoma ...

N4 Pharma ( ($GB:N4P) ) just unveiled an announcement. N4 Pharma has achieved a significant milestone in its collaboration with SRI by ...

Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in ...

That’s now happening. Researchers have uncovered genes that play a role in a number of chronic conditions. And they have invented new types of therapies to target their genetic roots. One of the most ...

His cuts will not just hurt vaccines ...

Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing.

Researchers unveiled a genetic editing method that uses small nuclear RNAs instead of CRISPR. This approach produced fewer ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is entering a collaboration and license option deal ...

SAN FRANCISCO (AP) _ The biotechnology field is littered with the debris of would-be miracle cures. These days, the buzz is building around a technology called ``RNA interference,'' whose legions of ...

MONTREAL--(BUSINESS WIRE)--AmorChem II Fund L.P. (''AmorChem'') is delighted to announce that its RNA Zipcode delivery program has been acquired by Kodikaz Therapeutic Solutions, Inc. (''Kodikaz''), a ...